PL2873660T3 - Pochodna indolokarboksyamidu - Google Patents

Pochodna indolokarboksyamidu

Info

Publication number
PL2873660T3
PL2873660T3 PL13816547T PL13816547T PL2873660T3 PL 2873660 T3 PL2873660 T3 PL 2873660T3 PL 13816547 T PL13816547 T PL 13816547T PL 13816547 T PL13816547 T PL 13816547T PL 2873660 T3 PL2873660 T3 PL 2873660T3
Authority
PL
Poland
Prior art keywords
indolecarboxamide
derivative
indolecarboxamide derivative
Prior art date
Application number
PL13816547T
Other languages
English (en)
Inventor
Takatoshi Kanayama
Hideki Kubota
Shunichiro Matsumoto
Tomoyuki Saito
Takafumi Shimizu
Naoto Katoh
Shigeo Matsui
Original Assignee
Astellas Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc. filed Critical Astellas Pharma Inc.
Publication of PL2873660T3 publication Critical patent/PL2873660T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL13816547T 2012-07-10 2013-07-09 Pochodna indolokarboksyamidu PL2873660T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012154322 2012-07-10

Publications (1)

Publication Number Publication Date
PL2873660T3 true PL2873660T3 (pl) 2017-02-28

Family

ID=49916054

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13816547T PL2873660T3 (pl) 2012-07-10 2013-07-09 Pochodna indolokarboksyamidu

Country Status (18)

Country Link
US (1) US9376449B2 (pl)
EP (1) EP2873660B1 (pl)
JP (1) JP6131951B2 (pl)
KR (1) KR102119372B1 (pl)
CN (1) CN104428286B (pl)
AR (1) AR091699A1 (pl)
AU (1) AU2013287758A1 (pl)
BR (1) BR112015000709B1 (pl)
CA (1) CA2878663C (pl)
EA (1) EA026090B1 (pl)
ES (1) ES2630653T3 (pl)
IL (1) IL236406A0 (pl)
MX (1) MX361463B (pl)
PH (1) PH12015500003A1 (pl)
PL (1) PL2873660T3 (pl)
PT (1) PT2873660T (pl)
TW (1) TW201416351A (pl)
WO (1) WO2014010602A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014010603A1 (ja) * 2012-07-10 2014-01-16 アステラス製薬株式会社 腹圧性尿失禁又は混合型尿失禁の治療又は予防用医薬組成物、及び該医薬組成物に含有される化合物のスクリーニング方法
ES2694049T3 (es) 2014-01-14 2018-12-17 Astellas Pharma Inc. Compuesto de indol
SMT202200201T1 (it) 2016-02-12 2022-07-21 Cytokinetics Inc Derivati di tetraidroisochinolina
CN116496251A (zh) * 2023-04-25 2023-07-28 浙江理工大学 一种1h-吲哚-2-酰胺化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2737725B1 (fr) 1995-08-08 1997-10-31 Valentonine Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament
EP0885210B2 (en) 1996-03-08 2008-06-18 Takeda Pharmaceutical Company Limited Tricylic compounds having binding affinity for melatonin receptors, their production and use
ZA9711051B (en) 1996-12-10 1999-06-09 Bristol Myers Squibb Co Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents
FR2907452B1 (fr) 2006-10-18 2008-12-12 Servier Lab "nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
ATE548371T1 (de) * 2006-12-08 2012-03-15 Takeda Pharmaceutical Tricyclische verbindung und deren medizinische verwendung
JP2011529477A (ja) 2008-07-30 2011-12-08 フエルレル インターナショナル,ソシエダッド アノニマ 1,6−ジヒドロ−2h−3−オキサ−6−アザ−as−インダセン化合物

Also Published As

Publication number Publication date
AR091699A1 (es) 2015-02-25
AU2013287758A1 (en) 2015-01-22
IL236406A0 (en) 2015-02-26
CN104428286B (zh) 2017-03-08
PT2873660T (pt) 2016-12-05
EP2873660A1 (en) 2015-05-20
US20150203505A1 (en) 2015-07-23
EP2873660A4 (en) 2015-11-25
MX2015000431A (es) 2015-03-12
US9376449B2 (en) 2016-06-28
TW201416351A (zh) 2014-05-01
CA2878663C (en) 2020-08-04
BR112015000709B1 (pt) 2021-10-13
BR112015000709A2 (pt) 2019-11-05
KR20150028340A (ko) 2015-03-13
PH12015500003A1 (en) 2015-03-02
CN104428286A (zh) 2015-03-18
WO2014010602A1 (ja) 2014-01-16
JP6131951B2 (ja) 2017-05-24
EP2873660B1 (en) 2016-10-26
ES2630653T3 (es) 2017-08-22
KR102119372B1 (ko) 2020-06-05
CA2878663A1 (en) 2014-01-16
EA026090B1 (ru) 2017-02-28
EA201590185A1 (ru) 2015-04-30
JPWO2014010602A1 (ja) 2016-06-23
MX361463B (es) 2018-12-06

Similar Documents

Publication Publication Date Title
DK2830816T3 (en) Hidtil ukendt coatingkoncept
DK3327112T3 (en) Agse-deficient stamme
ZA201409422B (en) Benzimidazole-proline derivatives
ZA201407694B (en) Substituted pyrrolidine-2-carboxamides
SG11201404344XA (en) Substituted pyrrolidine-2-carboxamides
ZA201408876B (en) Pyrrolotriazinone derivatives
EP2935220A4 (en) PERI-carbinol
IL236295A (en) The history of indanesulfamide
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
EP2934541A4 (en) NORIBOGAINE SUBSTITUTE
ZA201405108B (en) Substituted phenylazole derivative
PL2873660T3 (pl) Pochodna indolokarboksyamidu
SG11201404325VA (en) Pyrimidooxazocine derivatives as mtor - inhibitors
GB201201023D0 (en) Sharkbitze
GB201200226D0 (en) Kinibra
GB201200011D0 (en) Eggboiler